Authors: KAEBISCH A SEAY U WICKER S WEBER C LOHMEYER J ORTIGAO JFR PRALLE H

Citation: A. Kaebisch et al., COMPARISON OF DIFFERENT ANTISENSE OLIGONUCLEOTIDES AGAINST THE BCR ABL JUNCTION IN CHRONIC MYELOGENOUS LEUKEMIA - CELLULAR PHARMACOLOGY ANDIN-VITRO EFFICACY/, International journal of oncology, 8(5), 1996, pp. 859-864

Authors: KAEBISCH A BROKT S SEAY U LOHMEYER J JAEGER U PRALLE H

Citation: A. Kaebisch et al., EXPRESSION OF THE NERVE GROWTH-FACTOR RECEPTOR C-TRK IN HUMAN MYELOID-LEUKEMIA CELLS, British Journal of Haematology, 95(1), 1996, pp. 102-109

Authors: KAEBISCH A BROKT S SEAY U LOHMEYER J JAEGER U PRALLE H

Citation: A. Kaebisch et al., THE EXPRESSION OF THE NERVE GROWTH-FACTOR RECEPTOR, C-TRK IN BLASTS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) SEEMS TO BE ASSOCIATED WITH WORSE PROGNOSIS, Blood, 88(10), 1996, pp. 2246-2246

Authors: KABISCH A PERENYI L SEAY U LOHMEYER J PRALLE H

Citation: A. Kabisch et al., UNMODIFIED PHOSPHODIESTER ANTISENSE OLIGODEOXYNUCLEOTIDES TO THE BCR-ABL JUNCTION DO NOT SUPPRESS PHILADELPHIA-POSITIVE CLONOGENIC CELLS, Acta haematologica, 92(4), 1994, pp. 190-196

Authors: KAEBISCH A SEAY U LOHMEYER J PRALLE H

Citation: A. Kaebisch et al., C-TRK ONCOGENE IS EXPRESSED AND DEVELOPMENTALLY-REGULATED IN HUMAN MYELOID-LEUKEMIA CELL-LINES, Blood, 82(10), 1993, pp. 10000372-10000372